Happy news for our paper which is out today describing a noncanonical function fir the tyrosine degradation enzyme FAH in breast cancer | Science Advances www.science.org/doi/10.1126/...
science.org
A noncanonical function of the tyrosine degradation enzyme FAH drives CDK4/6 inhibitor resistance in breast cancer
Resistance to standard-of-care therapies remains a major clinical challenge in the treatment of the most common breast cancer, the hormone receptor–positive (HR+) subtype. Cyclin-dependent kinase 4/6 ...